Collectively, these data suggested that SS-31 reduced the release of the cytokines IL-1β and IL-18 in macrophages as well as in the lungs of IPF mice by inhibiting NLRP3 inflammasome activation. The gene discussed is IL1B; the disease is idiopathic pulmonary fibrosis.